Production (Stage)
Johnson & Johnson
JNJ
$152.94
$0.330.22%
NYSE
| 03/30/2025 | 12/29/2024 | 09/29/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.30% | 4.30% | 4.77% | 5.13% | 10.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.30% | 4.30% | 4.77% | 5.13% | 10.57% |
| Cost of Revenue | 7.42% | 4.61% | 4.84% | 4.21% | 10.12% |
| Gross Profit | 2.95% | 4.16% | 4.74% | 5.54% | 10.77% |
| SG&A Expenses | 5.47% | 8.16% | 7.64% | 9.61% | 15.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.76% | 8.16% | 8.14% | 5.90% | 11.14% |
| Operating Income | -4.68% | -5.57% | -3.50% | 3.21% | 9.12% |
| Income Before Tax | 32.60% | 10.79% | 25.22% | 39.01% | 64.32% |
| Income Tax Expenses | 60.28% | 50.98% | 72.75% | 94.10% | 102.09% |
| Earnings from Continuing Operations | 27.75% | 5.55% | 18.89% | 31.88% | 59.11% |
| Earnings from Discontinued Operations | -- | -- | -100.37% | 3,323.42% | 2,377.31% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.32% | -59.99% | -57.59% | 191.24% | 202.39% |
| EBIT | -4.68% | -5.57% | -3.50% | 3.21% | 9.12% |
| EBITDA | -2.78% | -3.53% | -2.32% | 3.36% | 9.16% |
| EPS Basic | -40.12% | -57.54% | -56.82% | 201.67% | 211.61% |
| Normalized Basic EPS | 1.00% | 2.13% | 11.66% | 18.74% | 22.42% |
| EPS Diluted | -39.94% | -57.43% | -56.62% | 203.01% | 213.75% |
| Normalized Diluted EPS | 1.20% | 2.03% | 11.88% | 18.96% | 22.70% |
| Average Basic Shares Outstanding | -6.29% | -8.04% | -3.51% | -3.37% | -1.83% |
| Average Diluted Shares Outstanding | -6.47% | -7.97% | -3.81% | -3.67% | -2.16% |
| Dividend Per Share | 4.20% | 4.47% | 4.74% | 5.02% | 5.31% |
| Payout Ratio | 1.39% | 2.32% | 2.07% | -0.75% | -0.75% |